WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , Scientific Journal Impact Factor (SJIF) , IFSIJ Measure of Journal Quality , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , Research Publication Rating and Indexing , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

ISSN 2457-0400

Impact Factor  :  7.675

WJAHR Citation

  All Since 2020
 Citation  105  60
 h-index  4  4
 i10-index  3  2

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased from  5.464 to 7.675 for Year 2026.

  • WJAHR: AUGUST ISSUE PUBLISHED

    AUGUST 2026 Issue has been successfully launched on AUGUST 2026.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR August 2026 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

Best Article Awards

World Journal of Advance Healthcare Research (WJAHR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

PREVALENCE OF ABNORMAL PAP SMEAR AMONG SAMPLE OF IRAQI WOMEN ATTENDING AL-BATOOL TEACHING HOSPITAL IN MOSUL

*Aya Mikdad Neamat, Dr. Omaya Fakhri Qassid Al-Harbawi

ABSTRACT

Background: The Papanicolaou (Pap) smear, introduced by Georgios Papanikolaou in the 1940s, remains a widely used method for detecting precancerous and cancerous changes of the uterine cervix, particularly in settings without organized screening programs. However, its sensitivity is limited, missing 30-50% of precancerous lesions per screening round. Aim: To estimate the prevalence of abnormal Pap smear results among women attending the cervical screening unit of Al-Batool Maternity Teaching Hospital in Mosul and to identify associated socio-demographic and clinical correlates. Methods: A hospital-based cross-sectional study was conducted among 132 married women aged 21-65 years presenting with leukorrhea, low backache, or abnormal vaginal bleeding. Data on demographics, smoking, hormonal contraceptive use, parity, family history of cervical cancer, chief complaints, and cytology results were collected through structured interviews and medical record review, then analyzed using Microsoft Excel 2010 and IBM-SPSS 20, with the chi-square test used for comparisons (significance at p<0.05). Results: Most women were ≥40 years (58.3%), married (91.7%), non-smokers (94.7%), and housewives (59.8%); half used hormonal contraceptives, and only 1.5% had a positive family history of cervical cancer. Irregular bleeding (36.4%) and post-coital bleeding (32.6%) were the most frequent complaints. Cytology showed inflammation in 84.8% of specimens, negative results in 14.4%, and atypical squamous cells of undetermined significance in 0.8%, with no high-grade lesions or malignancy detected. Abnormal results were significantly associated with nulliparity and a positive family history of cervical cancer (p=0.045 and p=0.015, respectively). Conclusion: Abnormal Pap smear findings, although uncommon in this sample, were significantly linked to nulliparity and family history of cervical cancer, underscoring the value of targeted opportunistic screening and continued follow-up in these higher-risk groups.

[Full Text Article] [Download Certificate]